Next annual conference

ESPACOMP logo 2020 hi-res

ESPACOMP is an international, non-profit association established to improve medication adherence.

ESPACOMP, the International Society for Medication Adherence, is an international scientific association dedicated to promoting cutting-edge research in the field of medication adherence to increase the quality of research and support dissemination, implementation and uptake of knowledge in healthcare systems and policies.

Annual Meeting

Please join us for the 24th ESPACOMP conference in Tallinn, Estonia November 05 through 07, 2020. This year’s conference will be focused on Integrating Patient Engagement & Real-World Data to Improve Medication Adherence


ESPACOMP supports several projects and initiatives including the EMERGE guidelines for reporting medication adherence, the ABC Taxonomy, educational programs, and much more.


ESPACOMP membership is available to researchers, clinicians, trainees, pharmacists, nurses, industry stakeholders, and others interested in medication adherence research.


Cutting-edge research, new health policies, economic updates and other emerging news in the field of medication adherence.


Registered participants


Abstracts submitted


Poster presentations



Latest News


Who is … Sabina De Geest

Sabina De Geest is a nurse who was trained clinically in heart transplantation at the University of Pittsburgh (US) and the UZ Leuven (Belgium). She is currently a professor in nursing science at the University of Basel in Switzerland where she is the Director of…

Read more

Follow us on Twitter

The ABC Taxonomy for medication adherence has now been translated into French and German. Thanks to our collaborators for their contributions!

Nouvelle formation courte interpro à Lyon: Soutien à l’adhésion thérapeutique @UnivLyon1 Une collaboration @SocMedAdherence @HESPERequipe @UNIGEnews @CHUVLausanne soutenue par @auvergnerhalpes Inscriptions
#entretienmotivationnel #adhesiontherapeutique

If you couldn't make it to #ESPACOMP2019, a video by @Charlotte__Poot and Hans Wouters may be the next best thing. See it at

Load More...